Drugs which may be used by certain optometrists Approved drugs.
(a) Administration and prescription of pharmaceutical agents. Optometrists who are certified to prescribe and administer pharmaceutical agents for therapeutic purposes under section 4.1 of the Optometric Practice and Licensure Act (35 P. S. § 244.4a), may prescribe and administer the drugs listed in subsection (b) in their practice of optometry.
(b) Allowable pharmaceutical products. Optometrists may prescribe and administer the following pharmaceutical products or the A-rated generic therapeutically equivalent drug:
(A) Pilocarpine nitrate and pilocarpine hydrochloride—diagnostic use only.
(iv) Adrenergic antagonists—diagnostic use only.
(6) Nonsteroidal antiinflammatory drugs—topical only.
(C) Intermediary metabolism inhibitors.
(I) Sodium sulfacetamide and sulfisoxazole.
(I) Penicillins—including in combination with clavulanic acid.
(-1-) First generation—cephalexin and cefadroxil.
(-2-) Second generation—cefaclor and cefuroxime.
(v) Antifungal and antiparasitic—topical only.
(A) Amphotericin B, nystatin, natamycin.
(B) Miconazole, ketoconazole, clotrimazole.
(8) Analgesic drugs—oral and topical.
(A) Codeine in combination with acetaminophen or aspirin.
(ii) Antihistamines and mast cell stabilizers—topical only.
Additional Drugs Approved by Secretary of Health April 5, 2003 Drugs approved for use by all therapeutically-certified optometrists: Topical Steroids Prednisolone Medrysone Fluorometholone Hydrocortisone Dexamethasone Rimexolone Loteprednol Triamcinolone Oral Steroids Prednisone Methylprednisolone
Commercially-available combination of drugs approved for use by optometrists.
Drugs approved for use by optometrists certified to treat GLAUCOMA Beta Adrenergic Receptor Blockers Non-Selective Timolol Levobunolol Metipranolol Carteolol Selective Betaxolol Levobetaxolol Cholinergic Receptor Agonists Direct Acting
Pilocarpine Carbachol Indirect Acting Physostigmine Demecarium Echothiophate Iodide Adrenergic Receptor Agonists Non-Selective Epinephrine Dipivefrin Selective Alpha 2 Agonists Apraclonidine Brimonidine Topical Carbonic Anhydrase Inhibitors Dorzolamide Brinzolamide Prostaglandin Analogs Eicosanoid Derivatives Latanoprost Travoprost Bimatoprost Docosanoid Derivatives Unoprostone
Commercially-available combination of drugs approved for use by optometrists.
June 28, 2003 Topical Antibacterial Providone-iodine (Betadine) October 4, 2003 Topical Solutions* Maxifloxacin (Vigamox) Gatifloxacin (Zymar) Cyclosporine Ophthalmic Emulsion *Topical solutions and products only, not oral or injectable formulations. March 2004 The Pennsylvania State Board of Optometry recently clarified that IQUIX, a new commercially available concentration of levofloxacin, is available for prescription by optometrists. May 22, 2004 Elestat (epinastine HCL ophthalmic solution) September 16, 2006 Nepafenac (Nevenac®) ophthalmic solution Bromfenac (Xibrom®) ophthalmic solution December 8, 2007 Zylet (Loteprednol Etabonate/Tobramycin combination) ophthalmic suspension
Professionalisation of interpreting in the community International Conference Critical Link 4 Adapting To Diversity Organizational Change at The Scarborough Hospital The Scarborough Hospital, Toronto, Canada Abstract Over the years the population changes in Scarborough, particularly with the broader diversity of ethnic and racial groups, have challenged The Scarborough
Current Status of Outcome Measures in Vasculitis:Focus on Wegener’s Granulomatosis and MicroscopicPolyangiitis. Report from OMERACT 7PETER A. MERKEL, PHILIP SEO, PETER ARIES, TUHINA NEOGI, ALEXANDRA VILLA-FORTE, MAARTEN BOERS, DAVID CUTHBERTSON, DAVID T. FELSON, BERNHARD HELLMICH, GARY S. HOFFMAN,DAVID R. JAYNE, CEES G.M. KALLENBERG, JEFFREY KRISCHER, ALFRED MAHR, ERIC L. MATTESON,ULRICH SPECKS